Efthimiadis A.Rosuvastatin and cardiovascular disease: did the strongest statin hold the initial promises?Angiology . 2008;59(2 suppl):62S-64S.
2.
Ridker PM, Danielson E., Fonseca FA, et al, for the JUPITER Study Group.Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med.2008;359(21):2195-2207.
3.
http://www.astrazeneca.com/search/?itemId=3892320. Accessed February 19, 2009.
4.
Mallinson JE , Constantin-Teodosiu D., Sidaway J., Westwood FR, Greenhaff PLBlunted Akt/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy. J Physiol.2009;587(pt 1):219-230.